Latest Commercialization News

Winchester Energy Limited reported steady production levels alongside ongoing cost reduction efforts in its December 2024 quarterly report, highlighting operational resilience despite currency headwinds.

Althea Group Holdings reported a 20% increase in customer receipts to $9.01 million for Q2 FY25, while addressing governance lapses and reviewing its FY25 guidance. The company is advancing operational improvements and cost savings as it prepares for a pivotal Federal Court hearing.

Kingston Resources Limited reported a $1.07 million net cash outflow from operating activities in the December 2024 quarter, maintaining a solid cash balance of nearly $9.9 million supported by a $15 million secured loan facility.

Nova Eye Medical Limited is raising A$6.6 million to strengthen its financial position following resolved supply chain disruptions, while reporting strong sales growth and nearing profitability in its glaucoma division.

Aeris Environmental Ltd reported a 5% revenue increase to $766,000 in the December 2024 quarter, driven by strong margins and momentum in its AerisTech joint venture. The company’s expanding customer base and strategic partnerships signal promising growth in smart building solutions and consumables.

Kingston Resources delivered robust production and revenue growth at Mineral Hill in Q4 2024, while advancing a strategic review of its Misima Gold Project to unlock further value.

Aguia Resources has commenced underground mining at its Santa Barbara gold project and secured a key court victory for its Brazilian phosphate project, supported by a $1.5 million capital raise.

4DS Memory Limited reports successful testing of its 60nm memory cells and progresses toward 20nm technology, alongside a $6 million capital raise and a new design partnership with Infineon.

BCAL Diagnostics is poised to launch its innovative BREASTEST® breast cancer diagnostic test in early 2025, backed by recent NATA accreditation, patent acceptance, and a $2.6 million R&D tax offset.

Northern Minerals reports a 15% increase in its Wolverine Deposit resource and secures $28 million in funding, advancing its Browns Range heavy rare earths project amid ongoing feasibility studies.

Prescient Therapeutics has secured FDA clearance to initiate its Phase 2 PTX-100 trial for relapsed cutaneous T-cell lymphoma, alongside progress in its cell therapy platforms and a solid cash position bolstered by a recent R&D rebate.

Akora Resources reports strong progress at its Bekisopa Iron Ore Project in Madagascar, highlighted by successful drilling results, completion of key technical studies, and official support from the Malagasy government. The company is on track to deliver a Pre-Feasibility Study by Q1 2025, aiming to produce high-grade direct shipping ore for steelmakers focused on decarbonisation.